4DMedical Limited (ASX:4DX) Directors Insider Transactions

The Directors and Chief Executives of 4DMedical Limited (ASX:4DX) are required by law to report any insider transaction activities i.e. buying, selling, option exercising the 4DMedical Limited's shares in the stock market. Below table shows the list of insider transactions as reported by 4DMedical Limited to the ASX stock exchange.

An insider trade occurs when an individual (such as a CEO, CFO or COO) that has non-public information about a company buys or sells shares of that company's stock. Tracking a company's insider trades is a metric that can be used to identify the direction that the company's executives believes that the company is headed. For example, if a number of insiders purchase more shares of a company, they may believe that the company will have strong future earnings and that the share price will increase in the near future.

4DMedical Limited Directors/Insider Transactions Activity

List of Insider trades activity from 4DMedical Limited (4DX).

DateDirectorDirector's TitleSharesValueNote
07 Apr 2021Bianchi (Lilian)Director (Non-Executive)3,3063,901Other at price 1.18 per share.
07 Apr 2021Guthrie (Lusia Halina)Director (Non-Executive)2,4092,842Other at price 1.18 per share.
07 Apr 2021Rathie (Bruce)Non Executive Chairman9,6385,723Other at price 0.59 per share.
20 Nov 2020Lee (Heath Norman)Former1,057,682--